This article is more than 5 years old. Information may no longer be current.

Thoracic malignancies specialist joins Fox Chase Cancer Center

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Yanis Boumber, MD, PhD, has joined the department of thoracic medical oncology and the molecular therapeutics program at Fox Chase Cancer Center.

Boumber specializes in the treatment of thoracic cancers, including lung cancer, mesothelioma and thymoma.

“Dr. Boumber is an accomplished scientist and a compassionate clinician,” Jonathan Chernoff, MD, PhD, chief scientific officer at Fox Chase, said in a press release. “His unique skill set is an important asset to the center as we pursue our mission to prevail over cancer.”

Boumber initially joined Fox Chase’s department of medical oncology in 2013 but left to join the staff at University of New Mexico Comprehensive Cancer Center.

“Having worked at Fox Chase earlier in my career, I enjoyed the atmosphere and culture of support here,” Boumber said in the release. “The caliber of Fox Chase’s clinicians and researchers is second to none. I look forward to joining the staff once again and offering comfort and care to all who walk through the doors.”